U.S. FDA@US_FDAToday, we approved a new medication for the treatment of Alzheimer’s disease, the second of a new category of medications approved for Alzheimer's that target the fundamental pathophysiology of the disease. https://fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-alzheimers-disease-treatment…7:19 PM · Jan 6, 2023·163.3K Views119 Retweets63 Quotes228 Likes12 Bookmarks
